Inhibition Of Tumor Necrosis Factor-alpha And Cyclooxigenase-2 By Isatin: A Molecular Mechanism Of Protection Against Tnbs-induced Colitis In Rats

Isatin, an indole alkaloid has been shown to have anti-microbial, anti-tumor and anti-inflammatory effects. Due to its findings, we evaluated whether this alkaloid would have any effect on TNBS-induced colitis. Animals (male Unib:WH rats, aged 8 weeks old) were induced colitis through a rectal administration of 2,4,6-trinitrobenzene sulphonic acid using a catheter inserted 8 cm into the rectum of the animals. The rats were divided into two major groups: non-colitic and colitic. The colitic group was sub-divided into 6 groups (10 animals per group): colitic non-treated, Isatin 3; 6; 12.5; 18.75 and 25 mg/kg. Our main results showed that the oral treatment with Isatin 6 and 25 mg/kg were capable of avoiding the increase in TNF-α, COX-2 and PGE 2 levels when compared to the colitic non-treated group. Interestingly, the same doses (6 and 25 mg/kg) were also capable of preventing the decrease in IL-10 levels comparing with the colitic non-treated group. The levels of MPO, (an indirect indicator of neutrophil presence), were also maintained lower than those of the colitic non-treated group. Isatin also prevented the decrease of SOD activity and increase of GSH-Px and GSH-Rd activity as well as the depletion of GSH levels. In conclusion, both pre-treatments (6 and 25 mg/kg) were capable of protecting the gut mucosa against the injury caused by TNBS, through the combination of antioxidant and anti-inflammatory properties, which, together, showed a protective activity of the indole alkaloid Isatin. © 2013 Elsevier Ireland Ltd. All rights reserved.20914855Monteleone, G., Caruso, R., Pallone, F., Targets for new immunomodulation strategies in inflammatory bowel disease (2013) Autoimmun. Rev., 13 (1), pp. 11-14Ko, J.K., Auyeung, K.K., Inflammatory bowel disease: Etiology, pathogenesis and current therapy (2013) Curr. Pharm. Des., , [Epub ahead of print]Cartes, M.J., Lobo, A.J., Travis SP on behalf of the IBD Section of the British Society of Gastroenterology (2004) Guidelines for the Management of Inflammatory Bowel Disease in Adults, Gut, 53 (SUPPL. 5), pp. V1-V16Travis, S.P., Stange, E.F., Lemann, M., Oresland, T., Chowers, Y., Forbes, A., D'Haens, G., Colitis, O., European evidence based consensus on the diagnosis and management of Crohn's disease: Current management (2006) Gut, 55 (SUPPL. 1), pp. 16-i35Bernstein, C.N., Fried, M., Krabshuis, J.H., Cohen, H., Eliakim, R., Fedail, S., Gearry, R., Watermeyer, G., World Gastroenterology Organization Practice Guidelines for the diagnosis and management of IBD in 2010 (2010) Inflamm. Bowel Dis., 16, pp. 112-124Prantera, C., Marconi, S., Glucocorticosteroids in the treatment of inflammatory bowel disease and approaches to minimizing systemic activity (2013) Ther. Adv. Gastroenterol., 6, pp. 137-156Sergent, T., Piront, N., Meurice, J., Toussaint, O., Schneider, Y.J., Anti-inflammatory effects of dietary phenolic compounds in an in vitro model of inflamed human intestinal epithelium (2010) Chem. Biol. Interact., 188, pp. 659-667Candido-Bacani Pde, M., Mori, M.P., Calvo, T.R., Vilegas, W., Varanda, E.A., Colus, I.M., In vitro assessment of the cytotoxic, apoptotic, and mutagenic potentials of isatin (2013) J. Toxicol. Environ. Health A, 76, pp. 354-362Pakravan, P., Kashanian, S., Khodaei, M.M., Harding, F.J., Biochemical and pharmacological characterization of isatin and its derivatives: From structure to activity (2013) Pharmacol. Rep., 65, pp. 313-335Silva, B.V., Isatin, a versatile molecule: Studies in Brazil (2013) J. Bras. Chem. Soc., 24, pp. 707-720Kandasamy, R., Park, S.J., Boyapalle, S., Mohapatra, S., Hellermann, G.R., Lockey, R.F., Mohapatra, S.S., Isatin down-regulates expression of atrial natriuretic peptide receptor A and inhibits airway inflammation in a mouse model of allergic asthma (2010) Int. Immunopharmacol., 10, pp. 218-225Matheus, M.E., Violante, F.D.A., Garden, S.J., Pinto, A.C., Fernandes, P.D., Isatins inhibit cyclooxygenase-2 and inducible nitric oxide synthase in a mouse macrophage cell line (2007) European Journal of Pharmacology, 556 (1-3), pp. 200-206. , DOI 10.1016/j.ejphar.2006.10.057, PII S001429990601243XMorris, G.P., Beck, P.L., Herridge, M.S., Depew, W.T., Szewczuk, M.R., Wallace, J.L., Hapten-induced model of chronic inflammation and ulceration in the rat colon (1989) Gastroenterology, 96 (3), pp. 795-803Bell, C.J., Gall, D.G., Wallace, J.L., Disruption of colonic electrolyte transport in experimental colitis (1995) Am. J. Physiol., 268, pp. 622-G630Winterbourn, C.C., Hawkins, R.E., Brian, M., Carrell, R.W., The estimation of red cell superoxide dismutase activity (1975) J. Lab. Clin. Med., 85, pp. 337-341Anderson, M.E., Determination of glutathione and glutathione disulfide in biological samples (1985) Methods in Enzymology, VOL. 113, pp. 548-555Yoshikawa, T., Naito, Y., Kishi, A., Tomii, T., Kaneko, T., Iinuma, S., Ichikawa, H., Kondo, M., Role of active oxygen, lipid peroxidation, and antioxidants in the pathogenesis of gastric mucosal injury induced by indomethacin in rats (1993) Gut, 34 (6), pp. 732-737Carlberg, I., Mannervik, B., Reduction of 2,4,6-trinitrobenzenesulfonate by glutathione reductase and the effect of NADP+ on the electron transfer (1986) Journal of Biological Chemistry, 261 (4), pp. 1629-1635Krawisz, J.E., Sharon, P., Stenson, W.F., Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity. Assessment of inflammation in rat and hamster models (1984) Gastroenterology, 87 (6), pp. 1344-1350Romero-Calvo, I., Ocon, B., Martinez-Moya, P., Suarez, M.D., Zarzuelo, A., Martinez-Augustin, O., De Medina, F.S., Reversible Ponceau staining as a loading control alternative to actin in Western blots (2010) Anal. Biochem., 401, pp. 318-320Te Velde, A.A., Verstege, M.I., Hommes, D.W., Critical appraisal of the current practice in murine TNBS-induced colitis (2006) Inflammatory Bowel Diseases, 12 (10), pp. 995-999. , DOI 10.1097/01.mib.0000227817.54969.5e, PII 0005472520061000000009Premanathan, M., Radhakrishnan, S., Kulangiappar, K., Singaravelu, G., Thirumalaiarasu, V., Sivakumar, T., Kathiresan, K., Antioxidant & anticancer activities of isatin (1H-indole-2,3-dione), isolated from the flowers of Couroupita guianensis Aubl (2012) Indian J. Med. Res., 136, pp. 822-826Paiotti, A.P., Miszputen, S.J., Oshima, C.T., De Oliveira Costa, H., Ribeiro, D.A., Franco, M., Effect of COX-2 inhibitor after TNBS-induced colitis in Wistar rats (2009) J. Mol. Histol., 40, pp. 317-324Oz, H.S., Zhong, J., De Villiers, W.J., Osteopontin ablation attenuates progression of colitis in TNBS model (2012) Dig. Dis. Sci., 57, pp. 1554-1561Oz, H.S., Zhong, J., De Villiers, W.J., Pegylated arginine deiminase downregulates colitis in murine models (2012) Mediators Inflamm., 2012, p. 813892Martinon, F., Signaling by ROS drives inflammasome activation (2010) Eur. J. Immunol., 40, pp. 616-619Bouzid, D., Gargouri, B., Mansour, R.B., Amouri, A., Tahri, N., Lassoued, S., Masmoudi, H., Oxidative stress markers in intestinal mucosa of Tunisian inflammatory bowel disease patients (2013) Saudi J. Gastroenterol., 19, pp. 131-135Biasi, F., Leonarduzzi, G., Oteiza, P.I., Poli, G., Inflammatory bowel disease: Mechanisms, redox considerations, and therapeutic targets (2013) Antioxid. Redox Signal., 19 (14), pp. 1711-1747Valko, M., Leibfritz, D., Moncol, J., Cronin, M.T.D., Mazur, M., Telser, J., Free radicals and antioxidants in normal physiological functions and human disease (2007) International Journal of Biochemistry and Cell Biology, 39 (1), pp. 44-84. , DOI 10.1016/j.biocel.2006.07.001, PII S1357272506002196Kannan, N., Guruvayoorappan, C., Protective effect of Bauhinia tomentosa on acetic acid induced ulcerative colitis by regulating antioxidant and inflammatory mediators (2013) Int. Immunopharmacol., 16, pp. 57-66Roessner, A., Kuester, D., Malfertheiner, P., Schneider-Stock, R., Oxidative stress in ulcerative colitis-associated carcinogenesis (2008) Pathol. Res. Pract., 204, pp. 511-524Quintana-Cabrera, R., Bolanos, J.P., Glutathione and gamma-glutamylcysteine in hydrogen peroxide detoxification (2013) Methods Enzymol., 527, pp. 129-144Oz, H.S., Chen, T.S., Nagasawa, H., Comparative efficacies of 2 cysteine prodrugs and a glutathione delivery agent in a colitis model (2007) Translational Research, 150 (2), pp. 122-129. , DOI 10.1016/j.trsl.2006.12.010, PII S1931524407000436Miralles-Barrachina, O., Savoye, G., Belmonte-Zalar, L., Hochain, P., Ducrotte, P., Hecketsweiler, B., Lerebours, E., Dechelotte, P., Low levels of glutathione in endoscopic biopsies of patients with Crohn's colitis: The role of malnutrition (1999) Clinical Nutrition, 18 (5), pp. 313-317. , DOI 10.1016/S0261-5614(98)80030-7You, Y., Fu, J.J., Meng, J., Huang, G.D., Liu, Y.H., Effect of N-acetylcysteine on the murine model of colitis induced by dextran sodium sulfate through up-regulating PON1 activity (2009) Dig. Dis. Sci., 54, pp. 1643-1650Kim, S.J., Jung, H.J., Hyun, D.H., Park, E.H., Kim, Y.M., Lim, C.J., Glutathione reductase plays an anti-apoptotic role against oxidative stress in human hepatoma cells (2010) Biochimie, 92, pp. 927-932De Faria, F.M., Luiz-Ferreira, A., Socca, E.A., De Almeida, A.C., Dunder, R.J., Manzo, L.P., Da Silva, M.A., Souza Brito, A.R., Effects of Rhizophora mangle on experimental colitis induced by TNBS in rats (2012) Evid Based Complement Alternat. Med., 2012, p. 753971Drew, J.E., Arthur, J.R., Farquharson, A.J., Russell, W.R., Morrice, P.C., Duthie, G.G., Salicylic acid modulates oxidative stress and glutathione peroxidase activity in the rat colon (2005) Biochemical Pharmacology, 70 (6), pp. 888-893. , DOI 10.1016/j.bcp.2005.06.011, PII S0006295205004016Cereser, C., Boget, S., Parvaz, P., Revol, A., Thiram-induced cytotoxicity is accompanied by a rapid and drastic oxidation of reduced glutathione with consecutive lipid peroxidation and cell death (2001) Toxicology, 163 (2-3), pp. 153-162. , DOI 10.1016/S0300-483X(01)00401-2, PII S0300483X01004012Borrelli, F., Fasolino, I., Romano, B., Capasso, R., Maiello, F., Coppola, D., Orlando, P., Izzo, A.A., Beneficial effect of the non-psychotropic plant cannabinoid cannabigerol on experimental inflammatory bowel disease (2013) Biochem. Pharmacol., 85, pp. 1306-1316Moussa, L., Bezirard, V., Salvador-Cartier, C., Bacquie, V., Lencina, C., Leveque, M., Braniste, V., Houdeau, E., A low dose of fermented soy germ alleviates gut barrier injury, hyperalgesia and faecal protease activity in a rat model of inflammatory bowel disease (2012) PLoS One, 7, p. 49547Nishitani, Y., Zhang, L., Yoshida, M., Azuma, T., Kanazawa, K., Hashimoto, T., Mizuno, M., Intestinal anti-inflammatory activity of lentinan: Influence on IL-8 and TNFR1 expression in intestinal epithelial cells (2013) PLoS One, 8, p. 62441De Almeida, A.B., Sanchez-Hidalgo, M., Martin, A.R., Luiz-Ferreira, A., Trigo, J.R., Vilegas, W., Dos Santos, L.C., De La Lastra, C.A., Anti-inflammatory intestinal activity of Arctium lappa L. (Asteraceae) in TNBS colitis model (2013) J. Ethnopharmacol., 146, pp. 300-310Cho, E.J., Shin, J.S., Noh, Y.S., Cho, Y.W., Hong, S.J., Park, J.H., Lee, J.Y., Lee, K.T., Anti-inflammatory effects of methanol extract of Patrinia scabiosaefolia in mice with ulcerative colitis (2011) J. Ethnopharmacol., 136, pp. 428-435Da Silva, M.S., Sanchez-Fidalgo, S., Talero, E., Cardeno, A., Da Silva, M.A., Villegas, W., Souza Brito, A.R., De La Lastra, C.A., Anti-inflammatory intestinal activity of Abarema cochliacarpos (Gomes) Barneby & Grimes in TNBS colitis model (2010) J. Ethnopharmacol., 128, pp. 467-475Wang, Q., Guo, X.-L., Wells-Byrum, D., Noel, G., Pritts, T.A., Ogle, C.K., Cytokine-induced epithelial permeability changes are regulated by the activation of the p38 mitogen-activated protein kinase pathway in cultured caco-2 cells (2008) Shock, 29 (4), pp. 531-537. , DOI 10.1097/SHK.0b013e318150737f, PII 0002438220080400000017Ma, T.Y., Iwamoto, G.K., Hoa, N.T., Akotia, V., Pedram, A., Boivin, M.A., Said, H.M., TNF-alpha-induced increase in intestinal epithelial tight junction permeability requires NF-kappa B activation (2004) Am. J. Physiol. Gastrointest. Liver Physiol., 286, pp. 367-G376Al-Sadi, R.M., Ma, T.Y., IL-1β causes an increase in intestinal epithelial tight junction permeability (2007) Journal of Immunology, 178 (7), pp. 4641-4649Schaffer, M., Bongartz, M., Hoffmann, W., Viebahn, R., Regulation of nitric oxide synthesis in wounds by IFN-γ depends on TNF-α (2006) Journal of Investigative Surgery, 19 (6), pp. 371-379. , DOI 10.1080/08941930600985710, PII L152X74417T3U100Park, Y.S., COX-2 inhibitors in inflammatory bowel disease: Friends or foes? (2007) Korean J. Gastroenterol., 50, pp. 350-355Rizzo, M.T., Cyclooxygenase-2 in oncogenesis (2011) Clin. Chim. Acta, 412, pp. 671-687Nagib, M.M., Tadros, M.G., Elsayed, M.I., Khalifa, A.E., Anti-inflammatory and anti-oxidant activities of olmesartan medoxomil ameliorate experimental colitis in rats (2013) Toxicol. Appl. Pharmacol., 271, pp. 106-113Otani, T., Yamaguchi, K., Scherl, E., Du, B., Tai, H.H., Greifer, M., Petrovic, L., Dannenberg, A.J., Levels of NAD(+)-dependent 15-hydroxyprostaglandin dehydrogenase are reduced in inflammatory bowel disease: Evidence for involvement of TNF-alpha (2006) Am. J. Physiol. Gastrointest. Liver Physiol., 290, pp. 361-G368Sheibanie, A.F., Yen, J.-H., Khayrullina, T., Emig, F., Zhang, M., Tuma, R., Ganea, D., The proinflammatory effect of prostaglandin E2 in experimental inflammatory bowel disease is mediated through the IL-23→IL-17 axis (2007) Journal of Immunology, 178 (12), pp. 8138-8147Wang, D., Dubois, R.N., The role of COX-2 in intestinal inflammation and colorectal cancer (2010) Oncogene, 29, pp. 781-788Jiang, G.-L., Nieves, A., Wha, B.I., Old, D.W., Dinh, D.T., Wheeler, L., The prevention of colitis by E prostanoid receptor 4 agonist through enhancement of epithelium survival and regeneration (2007) Journal of Pharmacology and Experimental Therapeutics, 320 (1), pp. 22-28. , http://jpet.aspetjournals.org/cgi/reprint/320/1/22, DOI 10.1124/jpet.106.111146Macdonald, T.T., Vossenkaemper, A., Fantini, M., Monteleone, G., Reprogramming the immune system in IBD (2012) Dig. Dis., 30, pp. 392-395Brant, S.R., Promises, delivery, and challenges of inflammatory bowel disease risk gene discovery (2013) Clin. Gastroenterol. Hepatol., 11, pp. 22-26Lindsay, J., Van Montfrans, C., Brennan, F., Van Deventer, S., Drillenburg, P., Hodgson, H., Te Velde, A., Sol Rodriguez Pena, M., IL-10 gene therapy prevents TNBS-included colitis (2002) Gene Therapy, 9 (24), pp. 1715-1721. , DOI 10.1038/sj.gt.3301841Zhou, Y., Wang, H., Liang, L., Zhao, W.C., Chen, Y., Deng, H.Z., Total alkaloids of Sophora alopecuroides increases the expression of CD4+ CD25+ Tregs and IL-10 in rats with experimental colitis (2010) Am. J. Chin. Med., 38, pp. 265-27